These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 157284)

  • 21. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
    Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
    Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
    Aggeler J; Risch J; Werb Z
    Biochim Biophys Acta; 1981 Jun; 675(1):62-8. PubMed ID: 6455162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the release of plasminogen activator from the isolated rat lung by serine proteinases.
    Klöcking HP; Jablonowski C; Markwardt F
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):375-9. PubMed ID: 6172878
    [No Abstract]   [Full Text] [Related]  

  • 25. Stimulated lymph node lymphocytes release a plasminogen activator.
    Maillard J; Toullet F; Favreau C; Chadenier F
    Ann Immunol (Paris); 1978; 129 C(4):499-502. PubMed ID: 697317
    [No Abstract]   [Full Text] [Related]  

  • 26. Modulation of the plasminogen activator/plasmin system in rat liver regenerating by recruitment of oval cells.
    Bisgaard HC; Santoni-Rugiu E; Nagy P; Thorgeirsson SS
    Lab Invest; 1998 Mar; 78(3):237-46. PubMed ID: 9520937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous vascular fibrinolytic activity in the local Shwartzman reaction.
    Bergstein JM
    Am J Pathol; 1977 Sep; 88(3):655-62. PubMed ID: 407799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system.
    Tappy L; Hauert J; Bachmann F
    Thromb Res; 1984 Jan; 33(2):117-24. PubMed ID: 6538346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of epithelial tissue plasminogen activator as a thrombolytic agent in a rabbit model of venous thrombosis.
    Electricwala A; Emeis JJ; Atkinson T
    J Pharmacol Exp Ther; 1986 Jul; 238(1):254-8. PubMed ID: 2425075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Animal experimental studies on fibrinolysis with streptokinase].
    Hauptmann J; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):915-22. PubMed ID: 94886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolytic enzyme in the lining walls of chronic subdural hematoma.
    Ito H; Komai T; Yamamoto S
    J Neurosurg; 1978 Feb; 48(2):197-200. PubMed ID: 146730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator content in heart tissue and perfusate under various experimental conditions.
    Lyutova LV; Andreenko GV; Perova EV; Malchikova LS
    Cor Vasa; 1983; 25(3):206-12. PubMed ID: 6684535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanism of physiological fibrinolysis.
    Wiman B; Collen D
    Nature; 1978 Apr; 272(5653):549-50. PubMed ID: 151233
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of a plasmin A-chain/t-PA B-chain hybrid enzyme with plasma inhibitors in vivo and in vitro.
    Wilson S; Chamberlain P; Dodd I; Esmail A; Robinson JH
    Thromb Haemost; 1990 Jun; 63(3):459-63. PubMed ID: 1698316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinolysis and liver regeneration.
    Rixon RH; Walker PR; Whitfield JF
    J Cell Physiol; 1977 Jul; 92(1):13-21. PubMed ID: 142776
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of MD-805 on plasminogen activator release by thrombin from isolated perfused dog leg.
    Hijikata-Okunomiya A; Kitaguchi H; Hirata M
    Thromb Res; 1987 Mar; 45(5):699-702. PubMed ID: 3590096
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization and antithrombotic action of tissue plasminogen activator.
    Bergqvist D; Nilsson IM; Pandolfi M
    Experientia; 1984 Jan; 40(1):67-8. PubMed ID: 6229416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration.
    Berman M; Leary R; Gage J
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1204-21. PubMed ID: 6252112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the anabolic steroid stanozolol on tissue plasminogen activator activity and plasmin inhibition in the rat.
    Smokovitis A; Binder BR
    Experientia; 1980 Sep; 36(9):1079-80. PubMed ID: 6448164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of alloxan-induced diabetes on tissue plasminogen activator activity and plasmin inhibition in the rat.
    Smokovitis A; Auerswald W; Binder BR
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):421-34. PubMed ID: 6459660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.